Metoflick 50 Tablet contains Metoclopramide 50mg, a potent gastroprokinetic and anti-emetic agent indicated for the management of severe nausea, vomiting, delayed gastric emptying, and gastrointestinal motility disorders. It helps in improving gastric transit, reducing discomfort, and alleviating persistent digestive symptoms.
Metoclopramide works by antagonizing dopamine receptors in the chemoreceptor trigger zone and enhancing cholinergic activity in the gastrointestinal tract. This dual mechanism ensures effective relief from nausea, vomiting, and delayed gastric emptying.
For distributors and healthcare suppliers, Metoclide 50 Tablet is a high-demand gastrointestinal therapy product, commonly prescribed in hospitals, gastroenterology clinics, and outpatient departments. Its strong demand across acute care and chronic management ensures consistent market turnover.
Adding Metoflick 50 Tablet to your digestive and anti-emetic therapy segment creates strong opportunities in pharmacies, hospitals, gastroenterology centers, export markets, and third-party manufacturing. Its proven clinical efficacy, rapid relief profile, and prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.